About this raise: ProVEDA, with a valuation of $135 million, is raising funds on Mundial Financial Group. The company has created a topical therapeutic formulation to enhance external analgesic activity and alleviate pain. ProVEDA’s Max Pain Relief is made using select plant extracts and essential oils and uses a patented delivery system for faster absorption and pain relief. The products are manufactured in FDA-registered facilities under strict regulatory compliance and come with a 30-day money-back guarantee. R. Scott Grizzle and Rowland Hanson founded ProVEDA in May 2020. The current crowdfunding campaign has a minimum target of $9,999.40 and a maximum target of $1.2 million. The campaign proceeds will be used for marketing and advertising, product research and development, operational expenses, and general working capital.

Expand

Investment Overview

Not Funded: $0

Deal Terms

Total Commitments ($USD)

Platform
Mundial Financial Group
Start Date
07/15/2024
Close Date
09/30/2024
Min. Goal
$9,999
Max. Goal
$1,199,999
Min. Investment

$250

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.70

Pre-Money Valuation

$135,000,000

Company & Team

Company

Year Founded
2020
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2C
Margin
Low
Capital Intensity
Low
Location
Miramar Beach, Florida
Business Type
Growth
Company Website
Visit Website

Team

Employees
2
Prior Founder Exits?
No
Founder Name
Rowland Hanson
Title
Co-Chairman and Co-CEO
Founder Name
Scott Grizzle
Title
Co-Chairman and Co-CEO

Funding data not publicly available

Financials

as of Fiscal Year 2023
 Revenue
$52,527
 Monthly Burn
$50,000
 Runway
0.5 months

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$52,527

$13,455

COGS

$91,257

$49,128

Tax

$2,200

$2,767

 

 

Net Income

$-1,106,941

$-3,889,988

Summary Balance Sheet

FY 2023 FY 2022

Cash

$23,526

$203,370

Accounts Receivable

$0

$0

Total Assets

$1,542,961

$1,943,888

Short-Term Debt

$2,048,374

$1,968,360

Long-Term Debt

$1,077,000

$1,077,000

Total Liabilities

$3,125,374

$3,045,360

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/30/2025 DealMaker Securities $134,691,363 $250 Equity - Common Active RegCF
09/30/2024 Mundial Financial Group $135,000,000 $0 Equity - Common Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Add to portfolio
ProVEDA on Mundial Financial Group 2024
Platform: Mundial Financial Group
Security Type: Equity - Common
Valuation: $135,000,000
Price per Share: $1.70

Follow company

Follow ProVEDA on Mundial Financial Group 2024

Buy ProVEDA's Deal Report

Warning: according to the close date for this deal, ProVEDA may no longer be accepting investments.

ProVEDA Deal Report

Get Kingscrowd's comprehensive report on ProVEDA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether ProVEDA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the ProVEDA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge